Global 3D Printed Drugs Market Forecast to 2027 - COVID-19 Impact and Analysis

News provided by

Oct 08, 2020, 14:30 ET

DUBLIN, Oct. 8, 2020 /PRNewswire/ -- The "3D Printed Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Dosage Forms; Technology, and Geography" report has been added to ResearchAndMarkets.com's offering.

The 3D printed drugs market was valued at US$ 28.52 million in 2019 and is expected to grow at a CAGR of 9.1% from 2020 to 2027 to reach US$ 57.03 million by 2027. The factors driving the 3D printed drugs market growth include the increasing adoption of personalized medicines, extensive research and development activities, and growing prevalence of dysphagia. The illegal use of 3D printing for manufacturing of drugs hinders the growth of the market.

3D printed drugs are medications that are designed by 3D printing technique to provide safe and effective customized drugs to the individuals. These drugs have unitary porous structures that readily disperse in the mouth, thus ruling out the necessity to sallow high-dose medicines intact. It enables manufacturers to easily adjust the size, appearance, shape, and rate of the delivery of a wide array of medicines. The growth of 3D printed drugs market is prominently attributed to the increasing adoption of personalized medicines and extensively growing R& D activities related to 3D printing. The implementation of 3D-printing technology to create personalized drug therapies is providing some exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express interest in purchasing customized products or services. This demand will definitely lead to growth of the 3D printing market by 2027. Moreover, since the Precision Medicine's Initiative was released in the US in 2015, pharmaceutical research organizations have been pursuing the development of more tailored treatments to make medicines safer and more effective.

The advantages of 3D printing such as its ability to offer personalized medicine system with an automated control over drug dose and suitability for both low and high drug concentrations allow drug companies to attain boosted efficacy and adherence of drugs as well as focus on their brand longevity by expanding and capturing market share with other dosage forms. FabRx Ltd., completed the world's first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, in April 2020, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines. The technique of 3D printing drugs could help make the medication safer and more attractive to children.

The global 3D printed drugs market is segmented by dosage form and technology. The 3D printed drugs market, by dosage form, is segmented into tablets, capsules, multi drug implant, nanoparticles, solutions, and other dosage forms. The tablet segment held the largest share of the market, and it is expected to register the highest CAGR in the market during the forecast period. Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, and stereo lithography (SLA). The zip dose held the largest share of technology segment in the global market; moreover, it is expected to register the fastest CAGR during the forecast period.

A few of the essential primary and secondary sources referred while preparing this report are the Food and Drug Administration (FDA), World Health Organization (WHO), Organization for Economic Co-operation and Development, National Institutes of Health (NIH), and Centers for Disease Control and Prevention (CDC), among

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the 3D printed drugs market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global 3D printed drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. 3D Printed Drugs Market - Key Takeaways

3. Research Methodology

4. Global 3D Printed Drugs Market - Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America- PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis

5. Global 3D Printed Drugs market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Adoption of Personalized Drugs
5.1.2 Increasing Prevalence of Dysphagia
5.2 Market Restraints
5.2.1 Usage of 3D Printing to Develop Illegal Drugs
5.3 Market Opportunities
5.3.1 Rising Awareness About the 3D Printing Technology
5.4 Future Trends
5.4.1 Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes
5.5 Impact analysis

6. 3D Printed Drugs Market- Global Analysis
6.1 Global 3D Printed Drugs Market Revenue Forecast And Analysis
6.2 Global 3D Printed Drugs Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. 3D Printed Drugs Market Analysis - By Dosage Forms
7.1 Overview
7.2 3D Printed Drugs Market Share, by Dosage Forms, 2019 and 2035, (%)
7.3 Tablets
7.3.1 Overview
7.3.2 Tablets: 3D Printed Drugs Market - Revenue and Forecast to 2027 (US$ Thousands)
7.3.3 Tablets: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
7.4 Capsules
7.4.1 Overview
7.4.2 Capsules: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
7.5 Multi Drug Implant
7.5.1 Overview
7.5.2 Multi Drug Implant: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
7.6 Nanoparticles
7.6.1 Overview
7.6.2 Nanoparticles: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
7.7 Solutions
7.7.1 Overview
7.7.2 Solutions: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
7.8 Other Dosage Forms
7.8.1 Overview
7.8.2 Other Dosage Forms: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)

8. 3D Printed Drugs Market Analysis - By Technology
8.1 Overview
8.2 3D Printed Drugs Market Share, by Technology, 2019 and 2035 (%)
8.3 Inkjet Printing
8.3.1 Overview
8.3.2 Inkjet Printing: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
8.4 Direct Write
8.4.1 Overview
8.4.2 Direct Write: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
8.5 Zip Dose
8.5.1 Overview
8.5.2 Zip Dose: 3D Printed Drugs Market- Revenue and Forecast to 2027 (US$ Thousands)
8.5.3 Zip Dose: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
8.6 Thermal Inkjet Printing
8.6.1 Overview
8.6.2 Thermal Inkjet: 3D Printed Drugs Market- Revenue and Forecast to 2035 (US$ Thousands)
8.7 Fused Deposition Modelling
8.7.1 Overview
8.7.2 Fused Deposition Modelling: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
8.8 Powder Bed Printing
8.8.1 Overview
8.8.2 Powder Bed Printing: 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
8.9 Stereolithography (SLA)
8.9.1 Overview
8.9.2 Stereolithography (SLA): 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)
8.10 Semi Solid Extrusion (SSE)
8.10.1 Overview
8.10.2 Semi Solid Extrusion (SSE): 3D Printed Drugs Market - Revenue and Forecast to 2035 (US$ Thousands)

9. 3D Printed Drugs Market - Geographic Analysis
9.1 North America: 3D Printed Drugs Market
9.2 Europe: 3D Printed Drugs Market
9.3 Asia Pacific: 3D Printed Drugs Market
9.4 Middle East & Africa: 3D Printed Drugs Market
9.5 South and Central America: 3D Printed Drugs Market

10. Impact Of COVID-19 Pandemic On Global Rare Neurological Diseases Treatment Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. 3D Printed Drugs Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview

12. Company Profiles
12.1 GlaxoSmithKline plc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Aprecia Pharmaceuticals, LLC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 AstraZeneca
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 Key Developments
12.4 FabRx Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Merck KGaA
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Cycle Pharmaceuticals
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Tvasta
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 MSD
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

For more information about this report visit https://www.researchandmarkets.com/r/7vd7s3

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets